Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ryoichi X. Ioka is active.

Publication


Featured researches published by Ryoichi X. Ioka.


Proceedings of the National Academy of Sciences of the United States of America | 2003

Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome

Toshiya Tanaka; Joji Yamamoto; Satoshi Iwasaki; Hiroshi Asaba; Hiroki Hamura; Yukio Ikeda; Mitsuhiro Watanabe; Kenta Magoori; Ryoichi X. Ioka; Keisuke Tachibana; Yuichiro Watanabe; Yasutoshi Uchiyama; Koichi Sumi; Haruhisa Iguchi; Sadayoshi Ito; Takefumi Doi; Takao Hamakubo; Makoto Naito; Johan Auwerx; Masashi Yanagisawa; Tatsuhiko Kodama; Juro Sakai

In this study, we defined the role of peroxisome proliferator-activated receptor β/δ (PPARδ) in metabolic homeostasis by using subtype selective agonists. Analysis of rat L6 myotubes treated with the PPARδ subtype-selective agonist, GW501516, by the Affymetrix oligonucleotide microarrays revealed that PPARδ controls fatty acid oxidation by regulating genes involved in fatty acid transport, β-oxidation, and mitochondrial respiration. Similar PPARδ-mediated gene activation was observed in the skeletal muscle of GW501516-treated mice. Accordingly, GW501516 treatment induced fatty acid β-oxidation in L6 myotubes as well as in mouse skeletal muscles. Administration of GW501516 to mice fed a high-fat diet ameliorated diet-induced obesity and insulin resistance, an effect accompanied by enhanced metabolic rate and fatty acid β-oxidation, proliferation of mitochondria, and a marked reduction of lipid droplets in skeletal muscles. Despite a modest body weight change relative to vehicle-treated mice, GW501516 treatment also markedly improved diabetes as revealed by the decrease in plasma glucose and blood insulin levels in genetically obese ob/ob mice. These data suggest that PPARδ is pivotal to control the program for fatty acid oxidation in the skeletal muscle, thereby ameliorating obesity and insulin resistance through its activation in obese animals.


Proceedings of the National Academy of Sciences of the United States of America | 2003

Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion

Takahiro Fujino; Hiroshi Asaba; Man Jong Kang; Yukio Ikeda; Hideyuki Sone; Shinji Takada; Dong Ho Kim; Ryoichi X. Ioka; Masao Ono; Hiroko Tomoyori; Minoru Okubo; Toshio Murase; Akihisa Kamataki; Joji Yamamoto; Kenta Magoori; Sadao Takahashi; Yoshiharu Miyamoto; Hisashi Oishi; Masato Nose; Mitsuyo Okazaki; Shinichi Usui; Katsumi Imaizumi; Masashi Yanagisawa; Juro Sakai; Tokuo T. Yamamoto

A Wnt coreceptor low-density lipoprotein receptor-related protein 5 (LRP5) plays an essential role in bone accrual and eye development. Here, we show that LRP5 is also required for normal cholesterol and glucose metabolism. The production of mice lacking LRP5 revealed that LRP5 deficiency led to increased plasma cholesterol levels in mice fed a high-fat diet, because of the decreased hepatic clearance of chylomicron remnants. In addition, when fed a normal diet, LRP5-deficient mice showed a markedly impaired glucose tolerance. The LRP5-deficient islets had a marked reduction in the levels of intracellular ATP and Ca2+ in response to glucose, and thereby glucose-induced insulin secretion was decreased. The intracellular inositol 1,4,5-trisphosphate (IP3) production in response to glucose was also reduced in LRP5−/− islets. Real-time PCR analysis revealed a marked reduction of various transcripts for genes involved in glucose sensing in LRP5−/− islets. Furthermore, exposure of LRP5+/+ islets to Wnt-3a and Wnt-5a stimulates glucose-induced insulin secretion and this stimulation was blocked by the addition of a soluble form of Wnt receptor, secreted Frizzled-related protein-1. In contrast, LRP5-deficient islets lacked the Wnt-3a-stimulated insulin secretion. These data suggest that Wnt/LRP5 signaling contributes to the glucose-induced insulin secretion in the islets.


Journal of Biological Chemistry | 2003

Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E.

Kenta Magoori; Man Jong Kang; Mitsuko R. Ito; Hajime Kakuuchi; Ryoichi X. Ioka; Akihisa Kamataki; Dong Ho Kim; Hiroshi Asaba; Satoshi Iwasaki; Yumiko A. Takei; Masako Sasaki; Shinichi Usui; Mitsuyo Okazaki; Sadao Takahashi; Masao Ono; Masato Nose; Juro Sakai; Takahiro Fujino; Tokuo T. Yamamoto

LDL receptor-related protein 5 (LRP5) plays multiple roles, including embryonic development and bone accrual development. Recently, we demonstrated that LRP5 is also required for normal cholesterol metabolism and glucose-induced insulin secretion. To further define the role of LRP5 in the lipoprotein metabolism, we compared plasma lipoproteins in mice lacking LRP5, apolipoprotein E (apoE), or both (apoE;LRP5 double knockout). On a normal chow diet, the apoE;LRP5 double knockout mice (older than 4 months of age) had ∼60% higher plasma cholesterol levels compared with the age-matched apoE knockout mice. In contrast, LRP5 deficiency alone had no significant effects on the plasma cholesterol levels. High performance liquid chromatography analysis of plasma lipoproteins revealed that cholesterol levels in the very low density lipoprotein and low density lipoprotein fractions were markedly increased in the apoE;LRP5 double knockout mice. There were no apparent differences in the pattern of apoproteins between the apoE knockout mice and the apoE;LRP5 double knockout mice. The plasma clearance of intragastrically loaded triglyceride was markedly impaired by LRP5 deficiency. The atherosclerotic lesions of the apoE;LRP5 double knockout mice aged 6 months were ∼3-fold greater than those in the age-matched apoE-knockout mice. Furthermore, histological examination revealed highly advanced arthrosclerosis, with remarkable accumulation of foam cells and destruction of the internal elastic lamina in the apoE;LRP5 double knockout mice. These data suggest that LRP5 mediates both apoE-dependent and apoE-independent catabolism of plasma lipoproteins.


Journal of Biological Chemistry | 2003

Expression Cloning and Characterization of a Novel Glycosylphosphatidylinositol-anchored High Density Lipoprotein-binding Protein, GPI-HBP1

Ryoichi X. Ioka; Man-Jong Kang; Shin Kamiyama; Dong-Ho Kim; Kenta Magoori; Akihisa Kamataki; Yuichiro Ito; Yumiko A. Takei; Masako Sasaki; Takashi Suzuki; Hironobu Sasano; Sadao Takahashi; Juro Sakai; Takahiro Fujino; Tokuo T. Yamamoto

By expression cloning using fluorescent-labeled high density lipoprotein (HDL), we isolated two clones that conferred the cell surface binding of HDL. Nucleotide sequence of the two clones revealed that one corresponds to scavenger receptor class B, type 1 (SRBI) and the other encoded a novel protein with 228 amino acids. The primary structure of the newly identified HDL-binding protein resembles GPI-anchored proteins consisting of an N-terminal signal sequence, an acidic region with a cluster of aspartate and glutamate residues, an Ly-6 motif highly conserved among the lymphocyte antigen family, and a C-terminal hydrophobic region. This newly identified HDL-binding protein designated GPI-anchored HDL-binding protein 1 (GPI-HBP1), was susceptible to phosphatidylinositol-specific phospholipase C treatment and binds HDL with high affinity (calculated K d = 2–3 μg/ml). Similar to SRBI, GPI-HBP1 mediates selective lipid uptake but not the protein component of HDL. Among various ligands for SRBI, HDL was most preferentially bound to GPI-HBP1. In contrast to SRBI, GPI-HBP1 lacked HDL-dependent cholesterol efflux. The GPI-HBP1 transcripts were detected with the highest levels in heart and, to a much lesser extent, in lung and liver. In situhybridization revealed the accumulation of GPI-HBP1 transcripts in cardiac muscle cells, hepatic Kupffer cells and sinusoidal endothelium, and bronchial epithelium and alveolar macrophages in the lung.


Journal of Biological Chemistry | 2005

SOX6 attenuates glucose stimulated insulin secretion by repressing PDX1 transcriptional activity and is down-regulated in hyperinsulinemic obese mice

Haruhisa Iguchi; Yukio Ikeda; Masashi Okamura; Toshiya Tanaka; Yasuyo Urashima; Hiroto Ohguchi; Shinobu Takayasu; Noriaki Kojima; Satoshi Iwasaki; Riuko Ohashi; Shuying Jiang; Go Hasegawa; Ryoichi X. Ioka; Kenta Magoori; Koichi Sumi; Takashi Maejima; Aoi Uchida; Makoto Naito; Timothy F. Osborne; Masashi Yanagisawa; Tokuo T. Yamamoto; Tatsuhiko Kodama; Juro Sakai

In obesity-related insulin resistance, pancreatic islets compensate for insulin resistance by increasing secretory capacity. Here, we report the identification of sex-determining region Y-box 6 (SOX6), a member of the high mobility group box superfamily of transcription factors, as a co-repressor for pancreatic-duodenal homeobox factor-1 (PDX1). SOX6 mRNA levels were profoundly reduced by both a long term high fat feeding protocol in normal mice and in genetically obese ob/ob mice on a normal chow diet. Interestingly, we show that SOX6 is expressed in adult pancreatic insulin-producing β-cells and that overexpression of SOX6 decreased glucose-stimulated insulin secretion, which was accompanied by decreased ATP/ADP ratio, Ca2+ mobilization, proinsulin content, and insulin gene expression. In a complementary fashion, depletion of SOX6 by small interfering RNAs augmented glucose-stimulated insulin secretion in insulinoma mouse MIN6 and rat INS-1E cells. These effects can be explained by our mechanistic studies that show SOX6 acts to suppress PDX1 stimulation of the insulin II promoter through a direct protein/protein interaction. Furthermore, SOX6 retroviral expression decreased acetylation of histones H3 and H4 in chromatin from the promoter for the insulin II gene, suggesting that SOX6 may decrease PDX1 stimulation through changes in chromatin structure at specific promoters. These results suggest that perturbations in transcriptional regulation that are coordinated through SOX6 and PDX1 in β-cells may contribute to the β-cell adaptation in obesity-related insulin resistance.


Journal of Biological Chemistry | 2001

Molecular Identification and Characterization of Two Medium-chain Acyl-CoA Synthetases, MACS1 and the Sa Gene Product

Takahiro Fujino; Yumiko A. Takei; Hideyuki Sone; Ryoichi X. Ioka; Akihisa Kamataki; Kenta Magoori; Sadao Takahashi; Juro Sakai; Tokuo T. Yamamoto

In this study, we identified and characterized two murine cDNAs encoding medium-chain acyl-CoA synthetase (MACS). One, designated MACS1, is a novel protein and the other the product of the Sa gene (Sa protein), which is preferentially expressed in spontaneously hypertensive rats. Based on the murine MACS1 sequence, we also identified the location and organization of the human MACS1 gene, showing that the human MACS1 and Sa genes are located in the opposite transcriptional direction within a 150-kilobase region on chromosome 16p13.1. Murine MACS1 and Sa protein were overexpressed in COS cells, purified to homogeneity, and characterized. Among C4–C16 fatty acids, MACS1 preferentially utilizes octanoate, whereas isobutyrate is the most preferred fatty acid among C2–C6 fatty acids for Sa protein. Like Sa gene transcript, MACS1 mRNA was detected mainly in the liver and kidney. Subcellular fractionation revealed that both MACS1 and Sa protein are localized in the mitochondrial matrix. 14C-Fatty acid incorporation studies indicated that acyl-CoAs produced by MACS1 and Sa protein are utilized mainly for oxidation.


Archive | 2000

Roles of Apolipoprotein E Receptors in Lipoprotein Metabolism

Tokuo Yamamoto; Yousuke Inagaki; Ryoichi X. Ioka; Shiroh Z. Yoshioka; Kenta Magoori; Man-Jong Kang; Yuko Cho; Akira Nakano; Qiong Liu; Takahiro Fujino; Dong-Ho Kim

Two apolipoprotein E (apoE) specific receptors, designated as ‘very low density lipoprotein receptor’ (VLDLR) and ‘apoE receptor 2’ (apoER2), closely resemble the structure of the low density lipoprotein receptor (LDLR), but they are expressed in different tissues. VLDLR mRNA is abundant in heart, skeletal muscle, brain and adipose tissues, whereas apoER2 mRNA predominates in the brain. In chicken, VLDLR is expressed almost exclusively in oocytes and mediates the uptake of yolk precursors, VLDL and vitellogenin. In contrast to the chicken, where absence of VLDLR results in an inability to lay eggs, the phenotype of VLDLR knockout mice is rather modest, except for a marked reduction of triacylglycerol content in adipose tissue, suggesting that VLDLR plays a part in the uptake of fat into adipocytes. Characterization of the apoER2 gene in various species has revealed the occurrence of an exon loss during its evolution and suggests that exon loss has contributed to the evolution of genes containing repetitive sequences. In addition to apoER2 and VLDLR, we have identified a new LDLR related protein (LRP) that recognizes apoE. This new LRP is expressed in the liver and steroidogenic tissues, suggesting a role in the clearance of apoE-lipoproteins.


Journal of Biochemistry | 1998

A New Low Density Lipoprotein Receptor Related Protein, LRP5, Is Expressed in Hepatocytes and Adrenal Cortex, and Recognizes Apolipoprotein E

Dong-Ho Kim; Yousuke Inagaki; Takashi Suzuki; Ryoichi X. Ioka; Shiroh Z. Yoshioka; Kenta Magoori; Man-Jong Kang; Yuko Cho; Akira Nakano; Qiong Liu; Takahiro Fujino; Hiroyuki Suzuki; Hironobu Sasano; Tokuo T. Yamamoto


Proceedings of the National Academy of Sciences of the United States of America | 2006

A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice

Shinobu Takayasu; Takeshi Sakurai; Satoshi Iwasaki; Hitoshi Teranishi; Akihiro Yamanaka; S. Clay Williams; Haruhisa Iguchi; Yuka Imamura Kawasawa; Yukio Ikeda; Iori Sakakibara; Kousaku Ohno; Ryoichi X. Ioka; Saori Murakami; Naoshi Dohmae; Jian Xie; Toshihiro Suda; Toshiyuki Motoike; Takashi Ohuchi; Masashi Yanagisawa; Juro Sakai


Journal of Biological Chemistry | 2004

A Krüppel-like factor KLF15 contributes fasting-induced transcriptional activation of mitochondrial acetyl-CoA synthetase gene AceCS2

Joji Yamamoto; Yukio Ikeda; Haruhisa Iguchi; Takahiro Fujino; Toshiya Tanaka; Hiroshi Asaba; Satoshi Iwasaki; Ryoichi X. Ioka; Izumi Kaneko; Kenta Magoori; Sadao Takahashi; Toshiyuki Mori; Hiroshi Sakaue; Tatsuhiko Kodama; Masashi Yanagisawa; Tokuo T. Yamamoto; Sadayoshi Ito; Juro Sakai

Collaboration


Dive into the Ryoichi X. Ioka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge